SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-016835
Filing Date
2019-03-22
Accepted
2019-03-22 16:40:58
Documents
5
Effectiveness Date
2019-03-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-2500_3defa14a.htm DEFA14A 31703
2 GRAPHIC g25003bci001.gif GRAPHIC 57447
3 GRAPHIC g25003bci002.gif GRAPHIC 94372
4 GRAPHIC g25003bci003.gif GRAPHIC 29904
5 GRAPHIC g25003bci004.gif GRAPHIC 3461
  Complete submission text file 0001104659-19-016835.txt   288121
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35565 | Film No.: 19700375
SIC: 2834 Pharmaceutical Preparations